Journal of Medical Economics, Volume 21, Issue 8 (2018)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 21, Issue 8 (2018)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Volume 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Ophthalmology

Article
Clinical trials with multiple endpoints can establish a correlation, but not (yet) causality, between dietary supplementation with omega-3 fatty acids and keratoconjunctivitis sicca
Roger Lee Mendoza
Pages: 733-744
Published online: 13 Jun 2018
AbstractforClinical trials with multiple endpoints can establish a correlation, but not (yet) causality, between dietary supplementation with omega-3 fatty acids and keratoconjunctivitis sicca | Full Text | References | PDF (1.1 MB)
  • 1045 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Dermatology

Article
Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity
Mwangi J. Murage, Amanda Anderson, Susan A. Oliveria, Deborah Casso, Clement K. Ojeh, Talia M. Muram, Joseph F. Merola & Andre B. Araujo
Pages: 745-754
Published online: 22 May 2018
AbstractforHealthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity | Full Text | References | PDF (869.6 KB)
  • 1867 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States
Lisa M. Hess, Zhanglin Lin Cui, Xiaohong Ivy Li, Ana B. Oton, Scott Shortenhaus & Ian A. Watson
Pages: 755-761
Published online: 11 May 2018
AbstractforDrug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States | Full Text | References | PDF (1.2 MB)
  • 1776 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Hematology

Article
Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States
Ellis J. Neufeld, Robert F. Sidonio Jr, Ken O’Day, M. Chris Runken, Kellie Meyer & Jeffrey Spears
Pages: 762-769
Published online: 06 Jun 2018
AbstractforCost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States | Full Text | References | PDF (791.8 KB)
  • 2088 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Dermatology

Article
Topical treatment utilization for patients with atopic dermatitis in the United States, and budget impact analysis of crisaborole ointment, 2%
Ryan Clark, Duygu Bozkaya, Mark Levenberg, Steven Faulkner, Timothy W. Smith & Robert A. Gerber
Pages: 770-777
Published online: 21 May 2018
AbstractforTopical treatment utilization for patients with atopic dermatitis in the United States, and budget impact analysis of crisaborole ointment, 2% | Full Text | References | PDF (1.6 MB)
  • 1845 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Neurology

Article
Economic evaluation of human urinary kallindinogenase for patients with acute ischemic stroke in China
Ziyi Lin, Xiuqin Rao, Zhijun Zhang & Jianwei Xuan
Pages: 778-783
Published online: 22 May 2018
AbstractforEconomic evaluation of human urinary kallindinogenase for patients with acute ischemic stroke in China | Full Text | References | PDF (1 MB) | Supplemental
  • 1002 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Pharmacoeconomic Trends

Article
Evaluating the accessibility of essential medicines in China
Xiaoyu Xi, Piaopiao Chen, Fan Yang, Yifan Yang, Lili Chen & Ningying Mao
Pages: 784-792
Published online: 11 Jun 2018
AbstractforEvaluating the accessibility of essential medicines in China | Full Text | References | PDF (831.7 KB)
  • 1246 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Healthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed/refractory multiple myeloma
Parameswaran Hari, Huamao Mark Lin, Yanyan Zhu, Deborah Berg, Paul G. Richardson & Philippe Moreau
Pages: 793-798
Published online: 29 May 2018
AbstractforHealthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed/refractory multiple myeloma | Full Text | References | PDF (574.8 KB)
  • 1749 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular Medicine

Article
Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective
Nimita Arora, Koji Makino, Dominic Tilden, Kyriakos Lobotesis, Peter Mitchell & John Gillespie
Pages: 799-809
Published online: 30 May 2018
AbstractforCost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective | Full Text | References | PDF (1.3 MB)
  • 2720 Views
  • 34 CrossRef citations
  • 0Altmetric
Free Access

Immunology

Article
Cost-effectiveness analysis of sequential biologic therapy with ixekizumab versus secukinumab as first-line treatment of moderate-to-severe psoriasis in the UK
Erin Colleen Johansson, Susanne Hartz, Sandeep Himatlal Kiri, Gayathri Kumar & Axel Svedbom
Pages: 810-820
Published online: 06 Jun 2018
AbstractforCost-effectiveness analysis of sequential biologic therapy with ixekizumab versus secukinumab as first-line treatment of moderate-to-severe psoriasis in the UK | Full Text | References | PDF (1.9 MB)
  • 1915 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USA
Michael S. Broder, Beilei Cai, Eunice Chang, Tingjian Yan & Al B. Benson III
Pages: 821-826
Published online: 25 May 2018
AbstractforFirst-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USA | Full Text | References | PDF (542.7 KB)
  • 573 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Hematology

Article
Cost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures
Christine L. Barnett, Deirdre Mladsi, Michael Vredenburg & Kavita Aggarwal
Pages: 827-834
Published online: 02 Jul 2018
AbstractforCost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures | Full Text | References | PDF (630.7 KB)
  • 6063 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Direct medical charges in a population-based systemic lupus erythematosus cohort
Daniel Bao et al.
Article | Published online: 25 Jul 2024
Open Access
The indirect costs of vaccine-preventable cancer mortality in the Middle East and North Africa (MENA)
Goran Bencina et al.
Article | Published online: 24 Jul 2024
Open Access
Modelling the opportunity for cost-savings or patient access with biosimilar adalimumab and tocilizumab: a European perspective
Kerise Clarke et al.
Article | Published online: 23 Jul 2024
Open Access
An assessment of the direct and indirect costs of bladder cancer preceding and following a cystectomy: a real-world evidence study
Joseph Tkacz et al.
Article | Published online: 23 Jul 2024
Open Access
View all latest articles